Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

909 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
Morishima S, Fukuda T, Doki N, Mori T, Onizuka M, Kawakita T, Kato C, Ozawa Y, Tanaka M, Kurokawa M, Kamimura T, Inoue M, Tanaka J, Ichinohe T, Atsuta Y, Morishima Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Morishima S, et al. Among authors: morishima y. Bone Marrow Transplant. 2021 Mar;56(3):646-654. doi: 10.1038/s41409-020-01070-3. Epub 2020 Oct 9. Bone Marrow Transplant. 2021. PMID: 33037403
Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant.
Nishida T, Akatsuka Y, Morishima Y, Hamajima N, Tsujimura K, Kuzushima K, Kodera Y, Takahashi T. Nishida T, et al. Among authors: morishima y. Br J Haematol. 2004 Mar;124(5):629-35. doi: 10.1111/j.1365-2141.2004.04823.x. Br J Haematol. 2004. PMID: 14871250 Free article.
[Hematopoietic stem cell transplantation].
Morishima Y. Morishima Y. Nihon Rinsho. 2005 Apr;63 Suppl 4:690-4. Nihon Rinsho. 2005. PMID: 15861730 Review. Japanese. No abstract available.
Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
Kanda Y, Sakamaki H, Sao H, Okamoto S, Kodera Y, Tanosaki R, Kasai M, Hiraoka A, Takahashi S, Miyawaki S, Kawase T, Morishima Y, Kato S; Japan Marrow Donor Program. Kanda Y, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2005 Nov;11(11):881-9. doi: 10.1016/j.bbmt.2005.07.005. Biol Blood Marrow Transplant. 2005. PMID: 16275591 Free article.
Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.
Imamura M, Asano S, Harada M, Ikeda Y, Kato K, Kato S, Kawa K, Kojima S, Morishima Y, Morishita Y, Nakahata T, Okamura J, Okamoto S, Shiobara S, Tanimoto M, Tsuchida M, Atsuta Y, Yamamoto K, Tanaka J, Hamajima N, Kodera Y. Imamura M, et al. Among authors: morishima y. Int J Hematol. 2006 Feb;83(2):164-78. doi: 10.1532/IJH97.05134. Int J Hematol. 2006. PMID: 16513537
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group. Hsu KC, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36. doi: 10.1016/j.bbmt.2006.04.008. Biol Blood Marrow Transplant. 2006. PMID: 16864053 Free article. Clinical Trial.
909 results